コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 se seen in the complexes with tacrolimus and ascomycin.
2 (NFAT), and that this was blocked by CsA and ascomycin.
3 complexes with two 32-indolyl derivatives of ascomycin.
4 etitively attenuated with the small molecule ascomycin.
8 ycin was prepared in a two-step process from ascomycin and evaluated for its immunosuppressant activi
10 ity (using cyclosporin or the FK506 analogue ascomycin, and a transfected C-terminal domain of the ca
11 analog, which was synthetically derived from ascomycin (ASC), the C21 ethyl analog of tacrolimus, by
12 thronolide B synthase gene was replaced with ascomycin AT8 and the engineered gene was expressed in S
14 CoA nor methylmalonyl-CoA is a substrate for ascomycin AT8 in its native context, both are substrates
15 s associated with the C24-hydroxyl moiety of ascomycin, C24-deoxyascomycin was found to be equipotent
16 olyl-ASC), a 32-O-(1-hydroxyethylindol-5-yl) ascomycin derivative with an improved therapeutic index
17 nists cyclosporin A and the FK-506 analogue, ascomycin, diminished costimulatory molecule and CD83 ex
20 3)C]glycerol is incorporated into C12-C15 of ascomycin, indicating that both modules 7 and 8 of the p
21 we achieved our goal with L-732,531 (indolyl-ascomycin; indolyl-ASC), a 32-O-(1-hydroxyethylindol-5-y
22 We found that both cyclosporine A (CsA) and ascomycin inhibited removal of cyclobutane pyrimidine di
23 contrast, pretreatment with cyclosporin A or ascomycin, inhibitors of protein phosphatase 2B activity
25 ed a new specificity for an AT domain in the ascomycin polyketide synthase and present evidence that
26 the acyl transferase (AT) of domain 8 in the ascomycin polyketide synthase was replaced with heterolo
27 erization and that of its competitive binder ascomycin required for dimerization inhibition were stud
28 2-Indole ether derivatives of tacrolimus and ascomycin retain the potent immunosuppressive activity o
29 the calcineurin inhibitors, cyclosporin A or ascomycin, significantly reduced the ability of 8-pCPT-2
30 s potency was markedly reduced compared with ascomycin when administered systemically due to more rap
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。